1. Home
  2. PAMT vs AMRN Comparison

PAMT vs AMRN Comparison

Compare PAMT & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAMT CORP

PAMT

PAMT CORP

HOLD

Current Price

$10.89

Market Cap

275.4M

Sector

Industrials

ML Signal

HOLD

Logo Amarin Corporation plc

AMRN

Amarin Corporation plc

HOLD

Current Price

$11.79

Market Cap

287.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAMT
AMRN
Founded
1980
1989
Country
United States
Ireland
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
275.4M
287.9M
IPO Year
1995
1998

Fundamental Metrics

Financial Performance
Metric
PAMT
AMRN
Price
$10.89
$11.79
Analyst Decision
Strong Sell
Analyst Count
0
2
Target Price
N/A
★ $12.50
AVG Volume (30 Days)
22.9K
★ 59.4K
Earning Date
11-03-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 55.00
EPS
N/A
★ N/A
Revenue
★ $437,838,000.00
$181,104,000.00
Revenue This Year
$17.76
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
1.15
★ 39.22
52 Week Low
$7.15
$11.25
52 Week High
$17.75
$20.57

Technical Indicators

Market Signals
Indicator
PAMT
AMRN
Relative Strength Index (RSI) 38.97 37.79
Support Level $9.39 N/A
Resistance Level $11.00 $14.50
Average True Range (ATR) 0.91 0.34
MACD -0.09 0.05
Stochastic Oscillator 19.86 55.34

Price Performance

Historical Comparison
PAMT
AMRN

About PAMT PAMT CORP

PAMT Corp is a holding company that is engaged in providing truckload dry van carrier services transporting general commodities throughout the continental United States and Mexico, as well as in certain Canadian provinces. Its freight consists of automotive parts, expedited goods, consumer goods, such as general retail store merchandise, and manufactured goods, such as heating and air conditioning units. It has one reportable segment being motor carrier.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Share on Social Networks: